the Differences Between Keppra and Trileptal for Epilepsy Treatment - Neurology

More Info

---

When it comes to the treatment of epilepsy, Keppra (levetiracetam) and Trileptal (oxcarbazepine) are two commonly prescribed medications, each with its own unique properties, mechanisms of action, and side effect profiles. Understanding the differences between these two drugs can help clarify why your doctor may have switched your medication.

Mechanism of Action:
Keppra works primarily by modulating neurotransmitter release through binding to the synaptic vesicle protein SV2A, which is thought to inhibit excessive neuronal firing. This makes it effective in controlling seizures, particularly in focal and generalized epilepsy. On the other hand, Trileptal is a prodrug that is converted to its active form, monohydroxy derivative (MHD), which stabilizes hyperexcitable neuronal membranes and inhibits repetitive neuronal firing by blocking sodium channels. This mechanism is similar to that of carbamazepine, another common antiepileptic drug.

Indications and Efficacy:
Both medications are used to treat partial seizures, but they may be chosen based on individual patient profiles and seizure types. Keppra is often favored for its rapid onset of action and relatively favorable side effect profile, particularly in patients who may be sensitive to cognitive side effects. Trileptal, while also effective, may be preferred in patients who have not responded well to other medications or who experience intolerable side effects from them.

Side Effects:
The side effects of Keppra can include fatigue, dizziness, irritability, and mood changes, while Trileptal may cause dizziness, drowsiness, double vision, and hyponatremia (low sodium levels). Importantly, Trileptal is often considered to have a lower risk of cognitive impairment compared to other antiepileptic drugs, which can be a significant factor in treatment decisions, especially for younger patients or those in school.

Reasons for Switching Medications:
Your doctor’s decision to switch from Keppra to Trileptal may not necessarily indicate a worsening of your condition. Instead, it could be based on several factors:
1. Side Effects: If you experienced side effects from Keppra that were intolerable, your doctor might have opted for Trileptal, which may have a different side effect profile.

2. Efficacy: If your seizures were not adequately controlled on Keppra, your doctor might have believed that Trileptal could provide better seizure control.

3. Patient Preference: Sometimes, the choice of medication can also be influenced by patient preference or lifestyle considerations.

Monitoring and Adjustment:
It’s important to note that the effectiveness of antiepileptic drugs can vary significantly from person to person. Your doctor will likely monitor your response to Trileptal closely, adjusting the dosage as necessary to achieve optimal seizure control while minimizing side effects. It may take several weeks to determine the full effectiveness of the new medication, as the body needs time to adjust.

In conclusion, the switch from Keppra to Trileptal is a common practice in epilepsy management and can be based on various clinical considerations. It’s essential to maintain open communication with your healthcare provider about your experiences with the medications, including any side effects or changes in seizure frequency. This collaborative approach will help ensure that you receive the most appropriate and effective treatment for your condition. If you have further questions or concerns, don’t hesitate to reach out to your doctor for clarification and guidance tailored to your specific situation.